| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032743890 |
| P356 | DOI | 10.1186/1742-4690-10-106 |
| P932 | PMC publication ID | 3827935 |
| P698 | PubMed publication ID | 24131498 |
| P5875 | ResearchGate publication ID | 257888319 |
| P50 | author | Mohamed S. Salama | Q29035467 |
| Douglas F. Nixon | Q44059330 | ||
| Steven G Deeks | Q57425986 | ||
| Satish K. Pillai | Q84362021 | ||
| P2093 | author name string | Xutao Deng | |
| Michael David | |||
| Elizabeth Sinclair | |||
| Rebecca Hoh | |||
| Joseph K Wong | |||
| Mohamed Abdel-Mohsen | |||
| Teri Liegler | |||
| Manqing Li | |||
| Rui André Saraiva Raposo | |||
| Hussam El-Din A Ghanem | |||
| P2860 | cites work | The interferon response inhibits HIV particle production by induction of TRIM22 | Q21131598 |
| Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag | Q21245043 | ||
| Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11 | Q24299226 | ||
| TRIM E3 ligases interfere with early and late stages of the retroviral life cycle | Q24310565 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection | Q24536249 | ||
| Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication | Q24563503 | ||
| The IFITM proteins inhibit HIV-1 infection | Q24629626 | ||
| Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein | Q24635842 | ||
| Human cytidine deaminase APOBEC3H restricts HIV-1 replication | Q24653682 | ||
| Primitive hematopoietic cells resist HIV-1 infection via p21 | Q24681819 | ||
| Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
| APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication | Q28286241 | ||
| CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 | Q28307312 | ||
| Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1 | Q28469342 | ||
| Cytidine deamination of retroviral DNA by diverse APOBEC proteins | Q28578747 | ||
| The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 | ||
| Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu | Q29547836 | ||
| HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
| Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome | Q29618742 | ||
| The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein | Q29619540 | ||
| Human TRIM gene expression in response to interferons | Q33418607 | ||
| Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity | Q33530091 | ||
| Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals | Q33535874 | ||
| Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct | Q33822538 | ||
| The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process | Q33826592 | ||
| APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. | Q34037651 | ||
| Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers | Q34189960 | ||
| The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences | Q34200151 | ||
| Human immunodeficiency virus long terminal repeat responds to T-cell activation signals | Q34350307 | ||
| Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers | Q34625953 | ||
| CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors | Q35216907 | ||
| Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity. | Q35668775 | ||
| Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo | Q35778972 | ||
| Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy | Q36304297 | ||
| Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study | Q36315197 | ||
| Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection | Q37078512 | ||
| Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals | Q37238299 | ||
| Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells | Q37252793 | ||
| Antiretroviral therapy and management of HIV infection | Q37770721 | ||
| HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control | Q38610690 | ||
| Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers. | Q39112993 | ||
| Unstimulated Primary CD4 + T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive Infection | Q39376055 | ||
| A whole genome screen for HIV restriction factors | Q39443387 | ||
| Small self-RNA generated by RNase L amplifies antiviral innate immunity | Q40180990 | ||
| Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers | Q40659603 | ||
| Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. | Q41827503 | ||
| Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors. | Q41862063 | ||
| Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease | Q42130441 | ||
| Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Q43858457 | ||
| HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. | Q44683563 | ||
| Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells | Q45883358 | ||
| Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. | Q51966653 | ||
| Mutations in thenefandvifgenes associated with progression to AIDS in elite controller and slow-progressor Patients | Q56782203 | ||
| How do HIV elite controllers do what they do? | Q84411178 | ||
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 106 | |
| P577 | publication date | 2013-10-16 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Expression profile of host restriction factors in HIV-1 elite controllers | |
| P478 | volume | 10 |
| Q33811660 | A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers |
| Q59360919 | A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis |
| Q36086989 | Antiviral gene expression in psoriasis |
| Q38760711 | BCL6 represses antiviral resistance in follicular T helper cells |
| Q35076655 | COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization |
| Q90628419 | Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress |
| Q55026249 | Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation. |
| Q35684549 | Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo |
| Q34261911 | Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo |
| Q64286953 | Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors |
| Q37547692 | Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo |
| Q39750445 | Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism |
| Q30153279 | Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection |
| Q89693845 | Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption |
| Q35462419 | Evolutionary distance of amino acid sequence orthologs across macaque subspecies: identifying candidate genes for SIV resistance in Chinese rhesus macaques |
| Q57455348 | Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy |
| Q37702075 | Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment |
| Q40354518 | Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa |
| Q28607258 | HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice |
| Q57096915 | HIV infection |
| Q40836975 | HIV-1 Infection Dysregulates Cell Cycle Regulatory Protein p21 in CD4+ T Cells Through miR-20a and miR-106b Regulation |
| Q26865803 | HIV-1 functional cure: will the dream come true? |
| Q38288593 | Hili Inhibits HIV Replication in Activated T Cells |
| Q40097257 | Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? |
| Q47141069 | Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection |
| Q38720858 | IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis |
| Q35785525 | IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection |
| Q38491184 | Innate immunity against HIV-1 infection |
| Q35944804 | Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth |
| Q47552023 | Interferons and beyond: Induction of antiretroviral restriction factors |
| Q38688274 | Mechanisms of HIV-1 Control |
| Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
| Q38379102 | Multiple Origins of Virus Persistence during Natural Control of HIV Infection |
| Q98939407 | Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection |
| Q39532298 | Relative mRNA Expression Levels of Restriction Factors and Antiviral Genes in Fetal and Adult Human Monocytes and Monocyte-Derived Macrophages |
| Q47553808 | Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients |
| Q64228805 | Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication |
| Q35295003 | Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo |
| Q43135641 | SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors |
| Q36645459 | SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load. |
| Q35271996 | Select host restriction factors are associated with HIV persistence during antiretroviral therapy |
| Q27025150 | Suppression of APOBEC3-mediated restriction of HIV-1 by Vif |
| Q41929461 | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
| Q39275728 | The Schlafen family: complex roles in different cell types and virus replication |
| Q39169410 | Therapeutic HIV vaccines: prior setbacks, current advances, and future prospects |
| Q47263592 | Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers. |
| Q52342680 | Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. |
| Q38348388 | Type I interferon: understanding its role in HIV pathogenesis and therapy |
| Q43074673 | miRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease |
Search more.